AMG592 (study 20200234) Site Recruitment Survey 2022
Amgen would like to invite you to participate in a brief survey on recruitment at your site. This should take only a few minutes and we would greatly appreciate your feedback.
1.
What is your Amgen site number for the 20200234 study (5 digit number)?
2.
What is your role on this study?
Principal Investigator
Investigator
Study Coordinator
Data Entry Coordinator
Other (please specify)
3.
How many subjects will your site be able to enroll by December 2022?
4.
How many subjects will your site be able to enroll by May 2023?
5.
If the enrollment period is extended, how many more could your site enroll by August 2023?
6.
If the enrollment period is extended, how many more could your site enroll by November 2023?
7.
What challenges are you currently facing with recruitment?
8.
What can Amgen do to help with recruitment?
Home Healthcare (available in select regions only)
Recruitment Materials (Posters, Brochures, etc.)
Referral Letters to aid in community outreach
Other (please specify)
9.
How many lupus studies is your site participating in at this time?
10.
What are the key factors that influence your decision on which trial to highlight to your patients?
11.
Name of person completing survey
